PRECIOUS HODGES: Open Payments
NPI 1841593464 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,454 in 47 payments from 12 companies in 2025. Trend: 2023 $21,331 · 2024 $26,211 · 2025 $11,454
Consulting: $6,500Travel & lodging: $3,929Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 24 | $10,835 |
| Calliditas Therapeutics US Inc. | 6 | $225 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
Products named: VELPHORO, TARPEYO, FARXIGA, JARDIANCE, OPTIFLUX, Fabhalta, ACTHAR, Vanrafia.
Industry payments across LA — which companies pay providers there.
